News and Trends 8 Jun 2023
Kate Therapeutics launches with $51M to develop genetic medicines for muscle and heart diseases
Gene therapy company Kate Therapeutics Inc. (KateTx), has emerged from stealth mode with a $51 million Series A financing. In addition, the company has granted Astellas Pharma Inc. an exclusive,…